Price$63.06-2.81 (-4.27%)
01:30 PM07:45 PM
News · 26 weeks97+75%
2026-01-182026-07-12
Mix4190d
- Insider17(41%)
- Other14(34%)
- Analyst4(10%)
- SEC Filings3(7%)
- Earnings2(5%)
- Dividends1(2%)
Latest news
25 items- PRCatholic Health and GE HealthCare partner to expand patient access across Long IslandMore than 1,300 pieces of technology to be added across Catholic Health hospitals and ambulatory locations, expanding access to advanced imaging, diagnostics and specialized care closer to home AI-powered technologies to support scheduling, operations, diagnostics, and monitoring across on-device, departmental and enterprise-level applications 10-year Care Alliance combines technology modernization with service support designed to help improve equipment reliability, operational efficiencies and care consistency across Catholic Health Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (NASDAQ:GEHC) announced today a 10-year strategic partners
- ANALYSTBMO Capital Markets initiated coverage on GE HealthCare with a new price targetBMO Capital Markets initiated coverage of GE HealthCare with a rating of Market Perform and set a new price target of $70.00
- PRGE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaborationA novel theranostics study explores imaging- and data-informed approaches to support individualized treatment decisions and expand access to theranostics Collaboration stems from a 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer. This collabor
- PRGE HealthCare to announce second quarter 2026 results on July 29, 2026GE HealthCare (NASDAQ:GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutic
- PRGE HealthCare announces cash dividend for second quarter of 2026The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 payable on August 14, 2026, to all shareholders of record as of July 24, 2026.About GE HealthCare Technologies Inc.GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Patient Care Solutions,
- PRGE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suitesUpgrade capabilities are designed to help health systems harness the latest Allia™ innovations while maximizing existing infrastructure investments GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime, and minimize disruption to clinical operations. As procedural complexity and patient volumes grow and installed systems age, healthc
- ANALYSTRBC Capital Mkts initiated coverage on GE HealthCare with a new price targetRBC Capital Mkts initiated coverage of GE HealthCare with a rating of Outperform and set a new price target of $80.00
- PRGE HealthCare advancing enterprise imaging with cloud-enabled solutionsGE HealthCare to showcase cloud-enabled solutions including Genesis Radiology Workspace and InteleShare at SIIM 2026 Enterprise imaging solutions are designed to help improve workflow and productivity, enabling better patient care GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical imaging departments today are under immense pressure from all sides including rising imaging volumes and increasing case complexity, while staffing shortages continue to grow. According to the American College of Radiology (ACR), radiologist workforce shortages have been identified as
- PRGE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesMarking the evolution of MIM AI-enabled auto-contouring software, MIM Contour ProtégéAI+ 2.0 introduces new models, including a Magnetic Resonance (MR) Brain model, as well as an updated Computed Tomography (CT) Male Pelvis model, expanding clinical capabilities across key anatomical regions. GE HealthCare will showcase MIM Contour ProtégéAI+ 2.0 at booth #202 during the American Association of Medical Dosimetrists 51st Annual Meeting taking place June 7-10, 2026 in Orlando, Florida. GE HealthCare (NASDAQ:GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI-enabled auto-contouring softw
- SECSEC Form SD filed by GE HealthCare Technologies Inc.SD - GE HealthCare Technologies Inc. (0001932393) (Filer)
- INSIDERDirector Lobo Kevin bought $641,800 worth of shares (10,000 units at $64.18), increasing direct ownership by 229% to 14,363 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- ANALYSTGE HealthCare upgraded by UBS with a new price targetUBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $69.00
- INSIDERCEO, AIS Rackliffe Philip was granted 16,458 shares, increasing direct ownership by 62% to 43,187 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERCEO, Patient Care Solutions Bankes Jeannette covered exercise/tax liability with 5,535 shares, decreasing direct ownership by 13% to 38,357 units (SEC Form 4) (tax withholding)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- PRCardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsIssued on behalf of Ventripoint Diagnostics Ltd.A Toronto-based small-cap is converting clinical validation into real-world hospital deployments at the moment AI cardiac imaging procurement is reorganizing globallyNEW YORK, May 19, 2026 /CNW/ -- USA News Group News Commentary — Cardiology has become one of the proving grounds for medical artificial intelligence, and the procurement environment around it has shifted hard in the last twelve months. Hospital networks are no longer content to evaluate clinical accuracy in isolation; they want department-level economic proof before they sign deployment contracts. That shift is reshaping which AI imaging companies can convert pilot data into recur
- SECAmendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)
- INSIDERDirector Hochman Rodney F bought $100,365 worth of shares (1,618 units at $62.03) (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- PRESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventionsThe company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway. At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (NASDAQ:GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company's presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care. According to the World Health Organization, cancer
- INSIDERDirector Yang Watkin Phoebe L. was granted 3,586 shares and bought $63,006 worth of shares (1,000 units at $63.01), increasing direct ownership by 50% to 13,702 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Culp H Lawrence Jr was granted 7,743 shares, increasing direct ownership by 61% to 20,442 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Hochman Rodney F was granted 6,275 shares, increasing direct ownership by 46% to 19,886 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Lesjak Catherine A was granted 3,586 shares, increasing direct ownership by 39% to 12,702 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Lobo Kevin was granted 3,586 shares, increasing direct ownership by 462% to 4,363 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Madden Anne T was granted 5,868 shares, increasing direct ownership by 43% to 19,479 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
GEHC FAQ
6 questionsWhere does GEHC stock trade?
GE HealthCare Technologies Inc. (GEHC) is listed on NASDAQ.What sector and industry is GEHC in?
GE HealthCare Technologies Inc. operates in the Health Care sector, Medical Electronics industry.Does GEHC pay a dividend?
Yes. GEHC's next ex-dividend date is 2026-07-24 with a declared cash dividend of $0.04 per share, payable 2026-08-14.What are analysts saying about GEHC?
GE HealthCare Technologies Inc. has had 8 recent analyst actions on file. The most recent action was from BMO Capital Markets: Market Perform on 2026-07-09.What companies are similar to GEHC?
Notable peers in the same industry include PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), BFLY (Butterfly Network Inc.), NNOX (NANO-X IMAGING LTD), CHEK (Check-Cap Ltd.). Compare GEHC side-by-side with any of them on Quantisnow.How can I track GEHC on Quantisnow?
Quantisnow aggregates GE HealthCare Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GEHC to receive live email and push alerts on every new disclosure.